SCIG Therapy for Primary Immunodeficiency and CVID: Treatment on Your Schedule
f you live with a primary immunodeficiency, you know the pattern: the sinus infection that will not clear, the bronchitis that comes back every season, the antibiotics that help for a while and then stop helping. For many patients with primary immunodeficiency (PI), including common variable immunodeficiency (CVID), immunoglobulin replacement therapy is the treatment that finally breaks that cycle. And for a growing number of those patients, subcutaneous immunoglobulin, or SCIG, is the form of therapy that fits their life best.
At Vital Care of Portland, we dispense multiple brands of SCIG and IVIG, train patients to self-administer at home, and coordinate everything with your immunologist. Here is what you should know.
What Is Primary Immunodeficiency?
Primary immunodeficiency is a group of more than 400 conditions in which part of the immune system is missing or does not work properly. The most common symptomatic form in adults is CVID, in which the body does not produce enough functional antibodies (immunoglobulins) to fight infection. People with CVID often experience repeated sinus and respiratory infections, gastrointestinal problems, and fatigue, and many go years before receiving an accurate diagnosis.
Because the underlying problem is missing antibodies, the cornerstone of treatment is straightforward in concept: replace them. Immunoglobulin replacement therapy provides the antibodies your body cannot make, using immunoglobulin purified from healthy plasma donors.
IVIG vs. SCIG: Two Ways to Replace Antibodies
Immunoglobulin replacement can be given two ways. Intravenous immunoglobulin (IVIG) is infused into a vein, usually every three to four weeks, with each session taking a few hours. Subcutaneous immunoglobulin (SCIG) is delivered through a small needle into the fatty tissue just under the skin, typically on the abdomen or thigh, usually once a week in smaller doses.
Both routes are effective at preventing infections. The right choice depends on your veins, your schedule, your tolerance of side effects, and your preference. Many patients start on IVIG and later transition to SCIG for maintenance.
Why Many PI and CVID Patients Choose SCIG
SCIG has some practical advantages that matter over a lifetime of therapy:
Steadier antibody levels. Weekly dosing avoids the peak-and-trough pattern of monthly IVIG, which for many patients means fewer wear-off symptoms like fatigue and infections in the days before the next dose.
No IV access needed. SCIG uses a small subcutaneous needle, which is a meaningful relief for patients with difficult veins or those who want to avoid ports.
Fewer systemic side effects. Headache, chills, and post-infusion fatigue are generally milder and less frequent with subcutaneous dosing. Local site reactions like redness or swelling are common early on and usually diminish with time.
Independence. After training, most patients self-administer at home, on their own schedule, without waiting for a nurse visit or an appointment. Infusions typically take about an hour, and many patients read, work, or watch a show while they infuse.
SCIG Products We Dispense
Vital Care of Portland dispenses multiple SCIG brands, and our pharmacists work with your immunologist to select and maintain the product that works for you. Options include conventional weekly SCIG products as well as facilitated SCIG, which uses hyaluronidase to allow larger doses given every three to four weeks. As with IVIG, product consistency matters, and we prioritize keeping you on the same brand infusion after infusion.
Training and Support: You Are Not Doing This Alone
The most common concern we hear from patients considering SCIG is simple: “Can I really do this myself?” The answer, for nearly everyone, is yes. Our infusion nurse provides hands-on training over your first several infusions, at home or in our Happy Valley infusion suite, until you are fully confident with the pump, tubing, and site preparation. After that, our pharmacists remain a phone call away, we ship your supplies directly to your door, and we check in regularly to make sure therapy is going smoothly.
Insurance Coverage for SCIG
Immunoglobulin therapy for PI and CVID is covered by most commercial plans, Medicare, and Oregon Medicaid when medical necessity is documented. Coverage rules differ between IVIG and SCIG and between medical and pharmacy benefits, and this is an area where our team does the heavy lifting. We bill through both medical and pharmacy benefits, manage the prior authorization and any appeals, and walk you through your expected out-of-pocket costs before you start.
Getting Started
If you or your child has been diagnosed with a primary immunodeficiency and your immunologist has recommended immunoglobulin therapy, we would be glad to help you explore whether SCIG is the right fit. Ask your specialist to send a referral, or contact our intake team:
Phone: 971-484-4940
Fax: 971-484-4950
Visit: vitalcareofportland.com
